A Pipeline Win as BridgeBio Learns to Balance Theory with Practice
RARECast - Un pódcast de RARECast - Jueves
Categorías:
Neil Kumar, co-founder and CEO of BridgeBio, discusses the approval of its ATTR-CM therapy Attruby, the company’s late-stage pipeline, and what he’s learned about its business model in the process.
